These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 30249439)

  • 21. Initial experience with the WATCHMAN™ left atrial appendage system for stroke prevention in atrial fibrillation: A single-centre registry.
    Bonnet G; Salaun E; Pankert M; Cuisset T; Bonnet JL
    Arch Cardiovasc Dis; 2016 Dec; 109(12):689-695. PubMed ID: 27594651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of Early (1-Week) Outcomes Following Left Atrial Appendage Closure With Amplatzer Devices.
    Koskinas KC; Shakir S; Fankhauser M; Nietlispach F; Attinger-Toller A; Moschovitis A; Wenaweser P; Pilgrim T; Stortecky S; Praz F; Räber L; Windecker S; Meier B; Gloekler S
    JACC Cardiovasc Interv; 2016 Jul; 9(13):1374-83. PubMed ID: 27388826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries.
    Holmes DR; Reddy VY; Gordon NT; Delurgio D; Doshi SK; Desai AJ; Stone JE; Kar S
    J Am Coll Cardiol; 2019 Dec; 74(23):2878-2889. PubMed ID: 31806131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single trans-septal access technique for left atrial intracardiac echocardiography to guide left atrial appendage closure.
    Aguirre D; Pincetti C; Perez L; Deck C; Alfaro M; Vergara MJ; Maluenda G
    Catheter Cardiovasc Interv; 2018 Feb; 91(2):356-361. PubMed ID: 28836342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-Term Oral Anticoagulation Versus Antiplatelet Therapy Following Transcatheter Left Atrial Appendage Closure.
    Asmarats L; O'Hara G; Champagne J; Paradis JM; Bernier M; O'Connor K; Beaudoin J; Junquera L; Del Val D; Muntané-Carol G; Côté M; Rodés-Cabau J
    Circ Cardiovasc Interv; 2020 Aug; 13(8):e009039. PubMed ID: 32772571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left Atrial Appendage Closure With the New Occlutech® Device: First in Man Experience and Neurological Outcome.
    Bellmann B; Schnupp S; Kühnlein P; Javernik C; Kleinecke C; Rillig A; Landmesser U; Brachmann J; Park JW
    J Cardiovasc Electrophysiol; 2017 Mar; 28(3):315-320. PubMed ID: 27925332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous Left Atrial Appendage Closure With the Watchman Device: Long-Term Results Up to 5 Years.
    Wiebe J; Franke J; Lehn K; Hofmann I; Vaskelyte L; Bertog S; Sievert H
    JACC Cardiovasc Interv; 2015 Dec; 8(15):1915-1921. PubMed ID: 26738659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pericardial Effusion After Left Atrial Appendage Closure: Timing, Predictors, and Clinical Impact.
    Galea R; Bini T; Krsnik JP; Touray M; Temperli FG; Kassar M; Papadis A; Gloeckler S; Brugger N; Madhkour R; Seiffge DJ; Roten L; Siontis GCM; Heg D; Windecker S; Räber L
    JACC Cardiovasc Interv; 2024 Jun; 17(11):1295-1307. PubMed ID: 38795087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First results of the Brazilian Registry of Percutaneous Left Atrial Appendage Closure.
    Guérios ÊE; Chamié F; Montenegro M; Saad EB; Brito FS; Caramori PA; Simões LC; Oliveira FRA; Giuliano LC; Tavares CMDF
    Arq Bras Cardiol; 2017 Nov; 109(5):440-447. PubMed ID: 29069203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety profiles of percutaneous left atrial appendage closure devices: An analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE) database from 2009 to 2016.
    Jazayeri MA; Vuddanda V; Turagam MK; Parikh V; Lavu M; Atkins D; Earnest M; Di Biase L; Natale A; Wilber D; Reddy YM; Lakkireddy DR
    J Cardiovasc Electrophysiol; 2018 Jan; 29(1):5-13. PubMed ID: 28988455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transition from WATCHMAN generation-2.5 device to WATCHMAN FLX device for percutaneous left atrial appendage closure: Incidence and predictors of device-related thrombosis and short- to mid-term outcomes.
    Chatani R; Kubo S; Tasaka H; Nishiura N; Mushiake K; Ono S; Maruo T; Kadota K
    Catheter Cardiovasc Interv; 2024 Aug; 104(2):318-329. PubMed ID: 38895767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous left atrial appendage closure in patients with primary hemostasis disorders and atrial fibrillation.
    Dognin N; Salaun E; Champagne C; Domain G; O'Hara G; Philippon F; Paradis JM; Faroux L; Beaudoin J; O'Connor K; Bernier M; Rodés-Cabau J; Champagne J
    J Interv Card Electrophysiol; 2022 Aug; 64(2):497-509. PubMed ID: 34822043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
    Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
    J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of left atrial appendage closure in non-valvular atrial fibrillation in patients over 75 years.
    Yu J; Chen H; Post F; Muenzel M; Keil T; Hou CR; Zhao M; Meng Z; Jiang L
    Heart Vessels; 2019 Nov; 34(11):1858-1865. PubMed ID: 31144099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and effectiveness of left atrial appendage closure in atrial fibrillation patients with different types of heart failure.
    Liu L; Yan W; Xu X; Wan C; Liu F; Yao Q; Song L; Wang B; Song Z; Li H
    BMC Cardiovasc Disord; 2024 Aug; 24(1):430. PubMed ID: 39148039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous left atrial appendage occlusion with the Amulet device: The impact of device disc position upon periprocedural and long-term outcomes.
    Oraii Yazdani K; Mitomo S; Ruparelia N; Candilio L; Giannini F; Jabbour RJ; Regazzoli D; Mazzone P; Stella S; Sora N; Montorfano M; Colombo A; Latib A
    Catheter Cardiovasc Interv; 2019 Jan; 93(1):120-127. PubMed ID: 30079565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Periprocedural intracardiac echocardiography for left atrial appendage closure: a dual-center experience.
    Berti S; Paradossi U; Meucci F; Trianni G; Tzikas A; Rezzaghi M; Stolkova M; Palmieri C; Mori F; Santoro G
    JACC Cardiovasc Interv; 2014 Sep; 7(9):1036-44. PubMed ID: 25234677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percutaneous left atrial appendage occlusion: Effect of device positioning on outcome.
    Wolfrum M; Attinger-Toller A; Shakir S; Gloekler S; Seifert B; Moschovitis A; Khattab A; Maisano F; Meier B; Nietlispach F
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):656-664. PubMed ID: 27465268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience.
    Chun KR; Bordignon S; Urban V; Perrotta L; Dugo D; Fürnkranz A; Nowak B; Schmidt B
    Heart Rhythm; 2013 Dec; 10(12):1792-9. PubMed ID: 23973952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real-world experience comparing two common left atrial appendage closure devices.
    Fastner C; Hoffmann L; Aboukoura M; Behnes M; Lang S; Borggrefe M; Akin I; Nienaber CA
    BMC Cardiovasc Disord; 2018 Aug; 18(1):171. PubMed ID: 30126370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.